|
ESRP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.377600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.025200E-04 |
| Normal-vs-Stage2 |
2.713600E-02 |
| Normal-vs-Stage3 |
8.556100E-02 |
| Normal-vs-Stage4 |
9.819500E-03 |
| Stage1-vs-Stage2 |
9.269000E-01 |
| Stage1-vs-Stage3 |
4.570000E-02 |
| Stage1-vs-Stage4 |
9.131600E-01 |
| Stage2-vs-Stage3 |
2.487800E-01 |
| Stage2-vs-Stage4 |
9.928000E-01 |
| Stage3-vs-Stage4 |
1.712420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.302280E-03 |
| Normal-vs-AfricanAmerican |
3.528000E-02 |
| Normal-vs-Asian |
5.101400E-03 |
| Caucasian-vs-AfricanAmerican |
5.990600E-01 |
| Caucasian-vs-Asian |
4.946000E-01 |
| AfricanAmerican-vs-Asian |
9.875400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.330260E-02 |
| Normal-vs-Female |
1.585640E-04 |
| Male-vs-Female |
3.592600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.849290E-04 |
| Normal-vs-Age(41-60Yrs) |
9.077400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.190120E-02 |
| Normal-vs-Age(81-100Yrs) |
7.319000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.195250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.515400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.824000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.180000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.907800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.321200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.459200E-01 |
| Classical-VS-Follicular |
8.072600E-01 |
| Classical-VS-Other |
6.437400E-01 |
| Classical-VS-Normal |
8.30470000000583E-05 |
| Tall-VS-Follicular |
4.822600E-01 |
| Tall-VS-Other |
9.824800E-01 |
| Tall-VS-Normal |
8.972300E-02 |
| Follicular-VS-Other |
7.798800E-01 |
| Follicular-VS-Normal |
1.259630E-02 |
| Other-VS-Normal |
2.885800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.179700E-03 |
| Normal-vs-N1 |
7.842500E-02 |
| N0-vs-N1 |
5.733600E-01 |
|
|
